Bladder squamous cell carcinoma (SCC) is a malignant tumor arising from squamous metaplasia of the bladder urothelial mucosa. It accounts for 2-5% of all bladder cancers in Western countries but 30-75% in Egypt and East Africa where Schistosoma haematobium is endemic. Chronic irritation (long-term catheterization, bladder stones, chronic UTI, schistosomiasis) is the main risk factor. Mean age at diagnosis is 55-65 years, with a 3:1 male predominance. Typically presents as a broad-based, sessile, invasive mass — papillary growth is rare. At diagnosis, 80% of patients have muscle invasion. Calcification is common, especially in schistosomiasis-associated cases where diffuse bladder wall calcification may be seen. Prognosis is worse than urothelial carcinoma — 5-year survival is 30-50% (muscle-invasive stage).
Age Range
50-80
Peak Age
65
Gender
Male predominant
Prevalence
Rare
Chronic irritation (schistosomiasis, long-term catheterization, bladder stones, recurrent infections) triggers the squamous metaplasia → dysplasia → carcinoma sequence in the bladder urothelial mucosa. Schistosoma haematobium eggs create chronic granulomatous inflammation in the bladder wall and direct urothelial cells toward squamous differentiation. During this process, keratin production begins — keratinized cells slightly increase tumor attenuation on CT and produce lower signal intensity on MRI T2 (compared to urothelial carcinoma). The tumor typically grows in a sessile, broad-based pattern and shows early muscle invasion — this results from rapid infiltration of the submucosal and muscular layers. In schistosomiasis-associated cases, bladder wall calcification is pathognomonic: dystrophic calcification forms around parasite eggs and appears as thin linear calcification on CT. Tumor neovascularity is less prominent than in urothelial carcinoma, so enhancement may be more heterogeneous and moderate.
Tramline pattern seen as two parallel thin calcification lines in the bladder wall on non-contrast CT. Reflects dystrophic calcification due to accumulation of Schistosoma haematobium eggs in the submucosa and muscular layer of the bladder wall. This finding is pathognomonic for schistosomiasis-associated bladder SCC and increases suspicion of malignancy when accompanied by a focal mass. Rare in non-endemic regions.
Thin linear calcification in the bladder wall (tramline pattern) on non-contrast CT. In schistosomiasis-associated cases, ring-like calcification encircling the entire bladder wall may be seen. Dystrophic calcification within or around the tumor mass is common. In non-schistosomiasis cases, calcification may be more focal and coarse.
Report Sentence
Thin linear/ring-shaped calcification is seen in the bladder wall on non-contrast CT, consistent with schistosomiasis-associated changes; in the presence of accompanying focal mass, SCC should be considered.
Broad-based, sessile, heterogeneously enhancing mass on the bladder wall on portal venous phase. Unlike urothelial carcinoma, does not show papillary architecture. Necrotic areas and intratumoral calcification are common. Perivesical fat invasion may be seen at early stage. Usually >3 cm and muscle-invasive at diagnosis.
Report Sentence
A broad-based, sessile, heterogeneously enhancing mass measuring approximately ___ mm is seen on the ___ wall of the bladder on portal venous phase, with accompanying intratumoral calcification; squamous cell carcinoma should be the primary consideration.
Intermediate-to-low signal intensity broad-based mass on the bladder wall on T2W MRI. Unlike urothelial carcinoma, T2 signal is generally lower — keratinization and fibrous stroma shorten T2 relaxation time. Necrotic areas may show high T2 signal creating a heterogeneous appearance. Detrusor muscle layer assessment is performed as in urothelial carcinoma — muscle layer is usually disrupted at diagnosis (T2+ stage).
Report Sentence
An intermediate-to-low signal intensity broad-based mass measuring approximately ___ mm is seen on the ___ wall of the bladder on T2W MRI, with the detrusor muscle layer assessed as ___; SCC should be considered due to keratinized features.
The broad-based bladder mass shows high signal on DWI, confirmed by low signal on ADC map. Diffusion restriction reflects tumor cellularity. Unlike urothelial carcinoma, stalk sign is generally not assessed (sessile growth pattern). Extension of DWI high signal into the muscle layer (usually present at diagnosis) confirms muscle invasion.
Report Sentence
The bladder mass shows marked diffusion restriction on DWI (ADC: low, ___ × 10⁻³ mm²/s) with restriction extending into the muscle layer.
Broad-based, hyperechoic or mixed-echogenicity sessile mass on the bladder wall on US. Keratinization and calcification areas produce strong echogenicity and acoustic shadowing. Linear calcification in the bladder wall may be detected in schistosomiasis-associated cases. Color Doppler may show moderate intratumoral vascularity. US is suitable for initial screening but CT is required for staging and calcification assessment.
Report Sentence
A broad-based, sessile, mixed-echogenicity mass measuring approximately ___ mm is seen on the ___ wall of the bladder on US, with accompanying calcification areas and acoustic shadowing.
Perivesical fat stranding around the bladder mass, adjacent organ invasion, and/or hydronephrosis due to ureteral orifice obstruction on delayed phase. As SCC tends to show early muscle invasion and locally advanced stage, perivesical invasion and adjacent organ involvement are frequently detected at diagnosis. Bilateral hydronephrosis suggests trigonal involvement.
Report Sentence
Irregular stranding in the perivesical fat around the bladder mass and ___lateral hydronephrosis are seen, suggesting locally advanced stage (T3+).
Criteria
SCC developing in the setting of Schistosoma haematobium infection. Dominant form in endemic regions (Egypt, East Africa). Younger age (mean 40-50). Accompanied by bladder wall calcification and chronic inflammation findings.
Distinct Features
Diffuse bladder wall calcification (tramline sign), well-differentiated keratinized histology predominant, generally low-to-intermediate grade, better prognosis (compared to non-bilharzial). Combination of calcified wall + focal mass on CT is characteristic. Distal ureter and renal pelvis may also be involved.
Criteria
SCC developing in the setting of chronic catheterization, bladder stones, recurrent UTIs, or neurogenic bladder. Dominant form in Western countries. Older age (mean 60-70). More aggressive course than schistosomiasis-associated cases.
Distinct Features
Wall calcification less prominent or absent, may have focal coarse calcification. High-grade histology predominant. Usually advanced stage at diagnosis (T3-T4). Worse prognosis (5-year survival 20-30%).
Criteria
Rare variant (1-3%). Papillomatous, exophytic, well-differentiated squamous tumor. Locally invasive but low metastatic potential.
Distinct Features
Unlike other SCC types, shows exophytic, papillomatous growth. Appears as lobulated, well-defined mass on CT/MRI. Keratinization is prominent. Muscle invasion occurs later. Good prognosis with surgical excision.
Distinguishing Feature
Urothelial carcinoma typically shows papillary growth pattern while SCC is sessile/broad-based. Calcification is rare in urothelial carcinoma but common in SCC. Urothelial carcinoma enhances more homogeneously while SCC enhances heterogeneously. History of chronic irritation supports SCC.
Distinguishing Feature
Adenocarcinoma most commonly localizes on the bladder dome (urachal origin) while SCC location is variable. Adenocarcinoma may show lower attenuation due to mucinous content. Urachal carcinoma presents as soft tissue mass between dome and umbilicus — this location is rare in SCC.
Distinguishing Feature
Cystitis shows diffuse wall thickening without focal mass formation. Does not show focal marked diffusion restriction on DWI. Rapid improvement after treatment. Focal mass + calcification + muscle invasion in SCC is distinguishing.
Distinguishing Feature
Radiation cystitis is associated with pelvic radiation history. Shows diffuse wall thickening and edema but no focal mass. Calcification is rare. Distribution correlates with radiation field. Focal mass and dystrophic calcification in SCC are distinguishing.
Urgency
urgentManagement
surgicalBiopsy
NeededFollow-up
specialist-referralDiagnosis of bladder SCC is confirmed by cystoscopy + TURBT biopsy. Staging is performed with CT + MRI. Treatment is usually radical cystectomy + pelvic lymphadenectomy (usually muscle-invasive at diagnosis). Unlike urothelial carcinoma, SCC is less responsive to cisplatin-based chemotherapy — therefore surgery is the primary treatment. Antiparasitic treatment accompanies schistosomiasis-associated cases. Immunotherapy efficacy is lower than in urothelial carcinoma. Prognosis is stage-dependent but generally worse than urothelial carcinoma.
Bladder SCC is more aggressive than TCC and is usually muscle-invasive at diagnosis. Schistosoma haematobium is the most common cause in endemic regions (Egypt, Middle East, Africa). Chronic bladder stones and prolonged catheterization are other risk factors. Treatment is usually radical cystectomy. Chemotherapy response is lower than TCC. 5-year survival rate is low (30-50%).